Antineoplastic Activity of the Combination Loratadine–Simvastatin–Gefitinib in HPV-Positive Cervical Cancer Cells: In Vitro and In Vivo Studies

Tania Raya-Bahena, Rene M. Rivera-Escobar, Elisabeth Hernández-Gallegos, Javier E. Jiménez-Salazar, Pablo Damián-Matsumura, Janice García-Quiroz, Javier Camacho · 2026

Read Antineoplastic Activity of the Combination Loratadine–Simvastatin–Gefitinib in HPV-Positive Cervical Cancer Cells: In Vitro and In Vivo Studies by Tania Raya-Bahena, Rene M. Rivera-Escobar, Elisabeth Hernández-Gallegos, Javier E. Jiménez-Salazar, Pablo Damián-Matsumura, Janice García-Quiroz, Javier Camacho (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13511572.txt.

Description

Simple SummaryCervical cancer (CC) is the most clinically significant HPV-associated malignancy, leading to thousands of deaths, especially in developing countries. Although cisplatin-based chemotherapy is the first-line treatment, the development of resistance and severe side effects frequently limits its use. Therefore, identifying safer and more effective therapeutic strategies is urgently needed.

Catalog record

CREATORTania Raya-Bahena, Rene M. Rivera-Escobar, Elisabeth Hernández-Gallegos, Javier E. Jiménez-Salazar, Pablo Damián-Matsumura, Janice García-Quiroz, Javier Camacho
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE26 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13511572

Browse the full library · About the Tower of Babel